View in EDS HTML Full Text PDF Full Text

Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.

Saved in:
Bibliographic Details
Title: Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Authors: Miller EJ; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, New York, USA., Rose TL; Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, USA., Maughan BL; Division of Hematology and Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Milowsky MI; Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, USA., Bilen MA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Carthon BC; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Gao X; Department of Internal Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rapisuwon S; Division of Hematology and Medical Oncology, Georgetown Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA., Zhao Q; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA., Yu M; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA., Agarwal N; Division of Hematology and Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Galsky MD; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, New York, USA.
Source: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1642-1649. Date of Electronic Publication: 2024 Jan 05.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38180804
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Miller+EJ%22">Miller EJ</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rose+TL%22">Rose TL</searchLink>; Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Maughan+BL%22">Maughan BL</searchLink>; Division of Hematology and Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Milowsky+MI%22">Milowsky MI</searchLink>; Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Bilen+MA%22">Bilen MA</searchLink>; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Carthon+BC%22">Carthon BC</searchLink>; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; Department of Internal Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rapisuwon+S%22">Rapisuwon S</searchLink>; Division of Hematology and Medical Oncology, Georgetown Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+Q%22">Zhao Q</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Yu+M%22">Yu M</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Agarwal+N%22">Agarwal N</searchLink>; Division of Hematology and Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Galsky+MD%22">Galsky MD</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2024 May 01; Vol. 130 (9), pp. 1642-1649. <i>Date of Electronic Publication: </i>2024 Jan 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38180804
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.35179
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1642
    Titles:
      – TitleFull: Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miller EJ
      – PersonEntity:
          Name:
            NameFull: Rose TL
      – PersonEntity:
          Name:
            NameFull: Maughan BL
      – PersonEntity:
          Name:
            NameFull: Milowsky MI
      – PersonEntity:
          Name:
            NameFull: Bilen MA
      – PersonEntity:
          Name:
            NameFull: Carthon BC
      – PersonEntity:
          Name:
            NameFull: Gao X
      – PersonEntity:
          Name:
            NameFull: Rapisuwon S
      – PersonEntity:
          Name:
            NameFull: Zhao Q
      – PersonEntity:
          Name:
            NameFull: Yu M
      – PersonEntity:
          Name:
            NameFull: Agarwal N
      – PersonEntity:
          Name:
            NameFull: Galsky MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 130
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1